Global Pharmaceuticals & Biotech Nano Cap Stocks

AB Science

Market Cap: €43.3m

A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.

Synbio Tech

Market Cap: NT$1.6b

Manufactures and sells human healthcare products and probiotics for animals.

TScan Therapeutics

Market Cap: US$49.4m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Haleos Labs

Market Cap: ₹4.6b

Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

CTCBIO

Market Cap: ₩69.8b

Provides various pharmaceutical products in South Korea and internationally.

Cantargia

Market Cap: SEK 453.0m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Ildong Holdings

Market Cap: ₩68.4b

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.

aTyr Pharma

Market Cap: US$47.1m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Norda

Market Cap: NOK 443.4m

A biotechnology company, engages in the cancer diagnostic activities.

Austar Lifesciences

Market Cap: HK$363.9m

An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.

Kidswell Bio

Market Cap: JP¥7.3b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$356.6m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

Vext Science

Market Cap: CA$63.2m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

BIO-FD&CLtd

Market Cap: ₩64.7b

Develops active ingredients for anti-aging cosmetics in South Korea.

Covalon Technologies

Market Cap: CA$61.9m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Sinsin Pharmaceutical

Market Cap: ₩62.8b

Manufactures and sells pharmaceutical products in South Korea.

Decibel Cannabis

Market Cap: CA$60.6m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Navamedic

Market Cap: NOK 398.1m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Planet 13 Holdings

Market Cap: CA$57.0m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

SkinBioTherapeutics

Market Cap: UK£29.8m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Sprint Bioscience

Market Cap: SEK 379.9m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

PDS Biotechnology

Market Cap: US$39.0m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.

Dyadic International

Market Cap: US$39.0m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

WDB coco

Market Cap: JP¥6.2b

Provides contract and human resource services to pharmaceutical companies in Japan.

Radiopharm Theranostics

Market Cap: AU$55.0m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Rhone Ma Holdings Berhad

Market Cap: RM 154.2m

An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.

MindMaze Therapeutics Holding

Market Cap: CHF 30.4m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

Botanix Pharmaceuticals

Market Cap: AU$52.0m

Operates as a commercial dermatology company in Australia and the United States.

Medical Developments International

Market Cap: AU$51.8m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Beit Jala Pharmaceutical

Market Cap: د.أ25.3m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

RP Bio

Market Cap: ₩51.6b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

P&K Skin Research Center

Market Cap: ₩50.1b

Engages in the evaluation and research of dermatological products in South Korea.

Infinium Pharmachem

Market Cap: ₹3.2b

Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.

Grace Therapeutics

Market Cap: US$33.7m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Winston Medical Supply

Market Cap: NT$1.1b

Develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Prince Pharmaceutical

Market Cap: NT$1.0b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.